FilingIndex
10-QThe Record

Keros Therapeutics, Inc. files 10-Q

Filed Nov 6, 2023 · 2y ago · Accession 0001664710-23-000066

Plain English

Quarterly report — three-month financials and management discussion.

Read the source below for the full document.

Read the original on SEC.gov ↗
Filing details
Ticker
KROS
CIK
1664710
Form type
10-Q
Filing date
Nov 6, 2023
Report date
Sep 30, 2023
Document
kros-20230930.htm
Size
4.1 MB